Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen concentrate plus standard transfusion support versus standard therapy for massive peri-operative or post-operative bleeding
NL-OMON31952Phase 3Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Feb 2009
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Fibrinogen human, fresh-frozen plasma and desmopressin in coagulopathy, perioperative hemorrhage and postoperative hemorrhage (4 arms), sponsored by Maastricht University. Primary endpoints: Amount of blood loss and Use of blood products. Started Feb 2009; status: active, not recruiting.
02
Drugs
Fibrinogen humanfresh-frozen plasmadesmopressin
03
Conditions
coagulopathyperioperative hemorrhagepostoperative hemorrhage
Beyond the preview
Go deeper on NL-OMON31952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31952.